Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin and Turmeric in Castration Sensitive Prostate Cancer on iADT
NCT06044025Phase 1Recruiting
- Sponsor
- University of Arkansas
- Start
- Apr 2024
- Primary completion
- Oct 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of liquid metformin (Aspargo Labs) and turmeric in prostate cancer (PCa), sponsored by University of Arkansas. Primary endpoints: Assess feasibility of recruitment at 12 months and Evaluate time to PSA relapse with nutritional intervention on iADT up to 27 months. Started Apr 2024; status: recruiting.
02
Drugs
liquid metformin (Aspargo Labs)turmeric
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT06044025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06044025.